We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Industry: Plan to Expand Off-Label Uses in France Undermines EU Regulation
Industry: Plan to Expand Off-Label Uses in France Undermines EU Regulation
The French National Assembly last month approved a proposal that would allow doctors to use less expensive off-label drugs even if an approved therapy exists — sparking cries from European drugmakers that the government is placing cost savings over patient safety.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor